Suppr超能文献

Birt-Hogg-Dubé 综合征合并考登综合征:两例综合征性嗜酸细胞瘤中镜像的遗传缺陷。

Where Birt-Hogg-Dubé meets Cowden syndrome: mirrored genetic defects in two cases of syndromic oncocytic tumours.

机构信息

Dip. Sc. Mediche e Chirurgiche-DIMEC, U.O. Genetica Medica, Policlinico Universitario S.Orsola-Malpighi, Bologna, Italy.

出版信息

Eur J Hum Genet. 2013 Oct;21(10):1169-72. doi: 10.1038/ejhg.2013.8. Epub 2013 Feb 6.

Abstract

Birt-Hogg-Dubè (BHD) is an autosomal dominant syndrome characterised by skin fibrofolliculomas, lung cysts, spontaneous pneumothorax and renal cancer. The association of benign cutaneous lesions and increased cancer risk is also a feature of Cowden Syndrome (CS), an autosomal dominant disease caused by PTEN mutations. BHD and CS patients may develop oncocytomas, rare neoplasias that are phenotypically characterised by a prominent mitochondrial hyperplasia. We here describe the genetic analysis of a parotid and a thyroid oncocytoma, developed by a BHD and a CS patient, respectively. The BHD lesion was shown to maintain the wild-type allele of FLCN, while losing one PTEN allele. On the other hand, a double heterozygosity for the same two genes was found to be the only detectable tumorigenic hit in the CS oncocytoma. Both conditions occurred in a context of high chromosomal stability, as highlighted by comparative genomic hybridisation analysis. We conclude that, similarly to PTEN, FLCN may not always follow the classical Two Hits model of tumorigenesis and may hence belong to a class of non-canonical tumour suppressor genes. We hence introduce a role of PTEN/FLCN double heterozygosity in syndromic oncocytic tumorigenesis, suggesting this to be an alternative determinant to pathogenic mitochondrial DNA mutations, which are instead the genetic hallmark of sporadic oncocytic tumours.

摘要

Birt-Hogg-Dubé (BHD) 是一种常染色体显性综合征,其特征为皮肤纤维毛囊瘤、肺囊肿、自发性气胸和肾癌。良性皮肤病变和癌症风险增加的关联也是 Cowden 综合征 (CS) 的特征,CS 是一种常染色体显性疾病,由 PTEN 突变引起。BHD 和 CS 患者可能会发展为嗜酸细胞瘤,这是一种罕见的肿瘤,其表型特征为明显的线粒体增生。我们在这里描述了由 BHD 和 CS 患者分别发展的腮腺和甲状腺嗜酸细胞瘤的遗传分析。BHD 病变显示保持 FLCN 的野生型等位基因,而失去一个 PTEN 等位基因。另一方面,在 CS 嗜酸细胞瘤中发现了这两个基因的双杂合性是唯一可检测到的肿瘤发生性打击。这两种情况都发生在高染色体稳定性的背景下,如比较基因组杂交分析所强调的那样。我们得出结论,与 PTEN 相似,FLCN 可能并不总是遵循经典的肿瘤发生的“两次打击”模型,因此可能属于一类非经典的肿瘤抑制基因。我们因此引入了 PTEN/FLCN 双杂合性在综合征性嗜酸细胞瘤发生中的作用,表明这是一种替代致病性线粒体 DNA 突变的决定因素,而后者是散发性嗜酸细胞瘤的遗传标志。

相似文献

1
Where Birt-Hogg-Dubé meets Cowden syndrome: mirrored genetic defects in two cases of syndromic oncocytic tumours.
Eur J Hum Genet. 2013 Oct;21(10):1169-72. doi: 10.1038/ejhg.2013.8. Epub 2013 Feb 6.
3
[Birt-Hogg-Dubé syndrome: an update].
Actas Dermosifiliogr. 2012 Apr;103(3):198-206. doi: 10.1016/j.ad.2011.07.009. Epub 2011 Sep 19.
9
Birt-Hogg-Dubé syndrome: Clinical and molecular aspects of recently identified kidney cancer syndrome.
Int J Urol. 2016 Mar;23(3):204-10. doi: 10.1111/iju.13015. Epub 2015 Nov 25.

引用本文的文献

5
Hamartoma Tumor Syndrome: Skin Manifestations and Insights Into Their Molecular Pathogenesis.
Front Med (Lausanne). 2021 Jul 27;8:688105. doi: 10.3389/fmed.2021.688105. eCollection 2021.
6
Inherited Thyroid Tumors With Oncocytic Change.
Front Endocrinol (Lausanne). 2021 Jun 9;12:691979. doi: 10.3389/fendo.2021.691979. eCollection 2021.
7
Parotid Oncocytoma as a Manifestation of Birt-Hogg-Dubé Syndrome.
Case Rep Radiol. 2018 Jun 3;2018:6265175. doi: 10.1155/2018/6265175. eCollection 2018.
8
Sporadic renal angiomyolipoma in a patient with Birt-Hogg-Dubé: chaperones in pathogenesis.
Oncotarget. 2018 Apr 24;9(31):22220-22229. doi: 10.18632/oncotarget.25164.
9
Clinical Features, Genetics and Potential Therapeutic Approaches for Birt-Hogg-Dubé Syndrome.
Expert Opin Orphan Drugs. 2015;3(1):15-29. doi: 10.1517/21678707.2014.987124. Epub 2014 Nov 29.
10
Mitochondrial DNA mutations distinguish bilateral multifocal renal oncocytomas from familial Birt-Hogg-Dubé tumors.
Mod Pathol. 2015 Nov;28(11):1458-69. doi: 10.1038/modpathol.2015.101. Epub 2015 Oct 2.

本文引用的文献

1
Regulation of mitochondrial oxidative metabolism by tumor suppressor FLCN.
J Natl Cancer Inst. 2012 Nov 21;104(22):1750-64. doi: 10.1093/jnci/djs418. Epub 2012 Nov 12.
2
Birt-Hogg-Dubé syndrome: from gene discovery to molecularly targeted therapies.
Fam Cancer. 2013 Sep;12(3):357-64. doi: 10.1007/s10689-012-9574-y.
4
Two distinct thyroid tumours in a patient with Cowden syndrome carrying both a 10q23 and a mitochondrial DNA germline deletion.
J Med Genet. 2011 Nov;48(11):779-82. doi: 10.1136/jmedgenet-2011-100152. Epub 2011 Sep 16.
5
PTEN loss in the continuum of common cancers, rare syndromes and mouse models.
Nat Rev Cancer. 2011 Apr;11(4):289-301. doi: 10.1038/nrc3037.
6
PTEN level in tumor suppression: how much is too little?
Cancer Res. 2011 Feb 1;71(3):629-33. doi: 10.1158/0008-5472.CAN-10-2488. Epub 2011 Jan 25.
8
Learning from oncocytic tumors: Why choose inefficient mitochondria?
Biochim Biophys Acta. 2011 Jun;1807(6):633-42. doi: 10.1016/j.bbabio.2010.08.006. Epub 2010 Aug 21.
9
Homozygous loss of BHD causes early embryonic lethality and kidney tumor development with activation of mTORC1 and mTORC2.
Proc Natl Acad Sci U S A. 2009 Nov 3;106(44):18722-7. doi: 10.1073/pnas.0908853106. Epub 2009 Oct 22.
10
Renal tumour suppressor function of the Birt-Hogg-Dubé syndrome gene product folliculin.
J Med Genet. 2010 Mar;47(3):182-9. doi: 10.1136/jmg.2009.072009. Epub 2009 Oct 19.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验